🇪🇺EU · EMAApplication withdrawnATC: B01AE07

Dabigatran etexilate Teva(dabigatran etexilate mesilate)

Venous Thromboembolism

Marketing Authorisation Holder: Teva GmbH

INN: dabigatran etexilate

Indication

Prevention of venous thromboembolic events

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Dabigatran etexilate Teva — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Ask about Dabigatran etexilate Teva Create Free Account

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.